ชื่อผู้ได้มา/จำหน่าย :?TROPHY CAPITAL GROWTH FUND | ประเภทหลักทรัพย์ : หุ้น | วันที่มีหน้าที่ : 01/04/2558

ชื่อผู้ได้มา/จำหน่าย :?ASIA PACIFIC GROWTH FUND II, L.P. | ประเภทหลักทรัพย์ : หุ้น | วันที่มีหน้าที่ : 28/10/2546

Constructions (2) Registration of 100 drugs formulas (54 formulas for human medicine and 46 formulas for animals) owned by the seller (3) Registration of special drug formulas, consisting of 12 formulas including

persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator

transferred on share sale and purchase date from the seller’s connected persons ) and related services i.e. registration with Food and Drug Administration (FDA), trademark permission, product and packaging

. registration with Food and Drug Administration (FDA), trademark permission, product and packaging design, and brand building etc. to customers who are business operator in skin cares and cosmetics. In addition

additional investments in plant, machinery, and office renovations to improve production efficiency and reduce production cost, for the Company’s sustainable growth in the future. However, some investments

the issuer’s core business. In any event, the issuer must not operate business in such a way that involves severely illegal business. For example, human trafficking, drug production or smuggling, or

international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug

measures to release the economic impact. Having considered the above-mentioned circumstances, the Bank of Thailand lowered the Thai economy growth outlook in 2020, from an increase of 1.5-2.5% to a decrease